Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
99.3 GBX | +0.51% | -2.17% | +22.59% |
01/05 | EARNINGS: Anexo revenue up; Maintel hails "confident start" to 2024 | AN |
01/05 | Concurrent Technologies Says Trading In First 4 Months In Line With Market Expectations | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.59% | 106M | - | ||
+7.88% | 53.68B | B- | ||
-17.99% | 14.79B | B | ||
+13.73% | 11.02B | B+ | ||
+7.95% | 8.92B | B | ||
+21.86% | 8.7B | B- | ||
+41.91% | 8.31B | D+ | ||
-10.55% | 8.12B | B- | ||
-11.91% | 6.93B | C- | ||
-12.27% | 6.92B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CNC Stock
- Ratings Concurrent Technologies Plc